- £198.21bn
- £217.54bn
- $54.07bn
- 85
- 16
- 86
- 71
REG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Ondexxya approved in Japan for FXai reversal
AnnouncementREG - AstraZeneca PLC - Evusheld approved in the EU for COVID-19
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - Evusheld Positive EU CHMP Opinion
AnnouncementREG - AstraZeneca PLC - Update on CALLA Phase III trial for Imfinzi
AnnouncementREG - AstraZeneca PLC - Notice of AGM
AnnouncementREG - AstraZeneca PLC - Settlement of patent litigation for Ultomiris
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - AstraZeneca PLC - Lynparza approved in US for early breast cancer
AnnouncementREG - AstraZeneca PLC - Update on US review of Fasenra in nasal polyps
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - AstraZeneca and Neurimmune close deal for NI006
AnnouncementREG - AstraZeneca PLC - Filing of Form 20-F with SEC
AnnouncementREG - AstraZeneca PLC - Chair succession planning update and Annual Report
AnnouncementREG - AstraZeneca PLC - Enhertu improves PFS and OS in HER2-low BC
Announcement